We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.85B
AUM Growth
+$519M
Cap. Flow
+$404M
Cap. Flow %
21.87%
Top 10 Hldgs %
27.4%
Holding
120
New
9
Increased
56
Reduced
4
Closed
10

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$54.3M
2
CYBR
CyberArk
CYBR
+$36.5M
3
ABBV icon
AbbVie
ABBV
+$26.6M
4
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
+$18.5M
5
IMPV
Imperva, Inc.
IMPV
+$18.2M

Top Sells

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$20.5M
2
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
+$11.8M
3
CXP
COLUMBIA PROPERTY TRUST, INC.
CXP
+$10.6M
4
VMW
VMware, Inc
VMW
+$8.02M
5
OII icon
Oceaneering
OII
+$7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.49%
2 Technology 26.09%
3 Consumer Discretionary 12.82%
4 Industrials 9.62%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
26
Tesla
TSLA
$1.22T
$29.6M 1.6%
1,654,500
+439,500
+36% +$6.95M
EXR icon
27
Extra Space Storage
EXR
$31.2B
$26.1M 1.41%
400,900
+170,000
+74% +$11.5M
STLD icon
28
Steel Dynamics
STLD
$36.2B
$25.1M 1.36%
1,211,900
+155,000
+15% +$3.34M
TRN icon
29
Trinity Industries
TRN
$2.64B
$24.1M 1.31%
1,268,296
– –
FPRX
30
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$23.8M 1.29%
957,900
+118,500
+14% +$2.64M
MDVN
31
DELISTED
MEDIVATION, INC.
MDVN
$23.8M 1.29%
416,400
– –
MGNX icon
32
MacroGenics
MGNX
$237M
$23.6M 1.28%
622,500
+206,200
+50% +$6.78M
CBI
33
DELISTED
Chicago Bridge & Iron Nv
CBI
$23.4M 1.27%
468,200
+145,100
+45% +$7.55M
VCYT icon
34
Veracyte
VCYT
$3.51B
$22.9M 1.24%
2,051,498
+533,998
+35% +$5.26M
CMRX
35
DELISTED
Chimerix, Inc.
CMRX
$22.7M 1.23%
490,800
+46,300
+10% +$1.86M
IMPV
36
DELISTED
Imperva, Inc.
IMPV
$22.3M 1.21%
+329,700
New +$18.2M
IDTI
37
DELISTED
Integrated Device Technology I
IDTI
$22.3M 1.21%
1,027,800
+251,700
+32% +$5.43M
NVAX icon
38
Novavax
NVAX
$1.21B
$21.3M 1.15%
95,435
– –
BWA icon
39
BorgWarner
BWA
$13B
$20.8M 1.13%
415,890
+30,218
+8% +$1.61M
SCTY
40
DELISTED
SolarCity Corporation
SCTY
$20M 1.08%
372,800
+183,800
+97% +$10.7M
NRG icon
41
NRG Energy
NRG
$28.1B
$19.6M 1.06%
856,100
+48,000
+6% +$1.2M
AGIO icon
42
Agios Pharmaceuticals
AGIO
$1.92B
$18.5M 1%
166,200
– –
PTLA
43
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$18.5M 1%
405,300
– –
IPHI
44
DELISTED
INPHI CORPORATION
IPHI
$18.3M 0.99%
799,100
– –
QLIK
45
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$18.2M 0.99%
+521,300
New +$18.5M
CPN
46
DELISTED
Calpine Corporation
CPN
$14.5M 0.78%
803,600
– –
STKL
47
DELISTED
SunOpta
STKL
$13.8M 0.75%
1,290,200
+63,500
+5% +$671K
TTPH
48
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$13.8M 0.74%
14,500
– –
COLL icon
49
Collegium Pharmaceutical
COLL
$1.14B
$13.3M 0.72%
+745,802
New +$12.9M
TEX icon
50
Terex
TEX
$7.22B
$13M 0.7%
557,400
+205,200
+58% +$5.41M
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Eventide Asset Management held 120 positions worth $1.85B, up 39% from $1.33B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $404M of net new capital in Q2 2015, opening 9 new positions and adding to 56 existing holdings. Its largest new stake was CyberArk: 570,000 shares worth $35.8M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was inContact, Inc., an estimated $443K trimmed.

  • Eventide Asset Management's largest Q2 2015 buy was CyberArk: 570,000 shares worth $35.8M.
  • Eventide Asset Management added most to Celgene Corp in Q2 2015, an estimated $54.3M increase.
  • Eventide Asset Management's biggest Q2 2015 reduction was inContact, Inc., cutting an estimated $443K.
  • Eventide Asset Management fully exited SANDISK CORP in Q2 2015, selling an estimated $20.5M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $1.85B portfolio in Q2 2015.
  • Eventide Asset Management opened 9 new positions and closed 10 in Q2 2015.
  • Eventide Asset Management's portfolio value rose 39% quarter-over-quarter to $1.85B.

Based on Eventide Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.